These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18143604)

  • 1. The in vivo action of aureomycin on pleuropneumonia-like organisms associated with various rheumatic diseases.
    BROWN TM; WICHELHAUSEN RH
    J Lab Clin Med; 1949 Oct; 34(10):1404-10. PubMed ID: 18143604
    [No Abstract]   [Full Text] [Related]  

  • 2. Pleuropneumonia-like organisms and their possible significance in collagenous diseases.
    WICHELHAUSEN RH; BROWN TM; ROBINSON LB; MERCHANT WR
    Ann Rheum Dis; 1951 Dec; 10(4):463-4. PubMed ID: 14895090
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further experiences with aureomycin therapy of acute rheumatism in children].
    SIKULA L
    Lek List; 1953 May; 8(9):213-5. PubMed ID: 13070689
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of aureomycin on acute rheumatism in children].
    CHURA AJ; SIKULA L; SITAY S; PRONAY K
    Lek List; 1951 Nov; 6(22):682-5; concl. PubMed ID: 14898856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of aureomycin in acute rheumatism in children].
    CHURA AJ; SIKULA L; SITAY S; PRONAY K
    Lek List; 1951 Nov; 6(21):648-54; contd. PubMed ID: 14898847
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pleuropneumonia-like organisms on cultured human cells.
    Fogh J; Hahn E; Fogh H
    Exp Cell Res; 1965 Sep; 39(2):554-66. PubMed ID: 5320215
    [No Abstract]   [Full Text] [Related]  

  • 7. Pleuropneumonialike organisms and L forms of bacteria.
    MINCK R; KIRN A
    Ann N Y Acad Sci; 1960 Jan; 79():658-61. PubMed ID: 14422738
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and distribution of oral pleuropneumonialike and L organisms.
    BURNETT GW; GILMORE E
    J Dent Res; 1959; 38(3):632. PubMed ID: 13654617
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion of pleuropneumonialike organisms to bacteria.
    SMITH PF; PEOPLES DM; MORTON HE
    Proc Soc Exp Biol Med; 1957 Nov; 96(2):550-3. PubMed ID: 13485161
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibiting action of aureomycin on bacterial respiration and oxidation of acids of the citric cycle].
    OSTEUX R; LATURAZE J; BURCK J
    C R Hebd Seances Acad Sci; 1952 Sep; 235(10):554-6. PubMed ID: 13020010
    [No Abstract]   [Full Text] [Related]  

  • 11. Further observations on the incidence and significance of pleuropneumonia-like organisms.
    DIENES L; BERG RL; WEINBERGER HJ
    Ann Rheum Dis; 1948 Dec; 7(4):259. PubMed ID: 18207853
    [No Abstract]   [Full Text] [Related]  

  • 12. Infectious synovitis control by medication; effect of strain differences and pleuropneumonia-like organisms.
    OLSON NO; SHELTON DC; MUNRO DA
    Am J Vet Res; 1957 Oct; 18(69):735-9. PubMed ID: 13470226
    [No Abstract]   [Full Text] [Related]  

  • 13. The relation of the in vitro sensitivity test to the clinical response to aureomycin therapy.
    SCHWEINBURG FB; SYLVESTER EM; RUTENBURG AM
    Surgery; 1954 Feb; 35(2):204-12. PubMed ID: 13135889
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stimulating and bactericidal effect of aureomycin on Breslau bacteria in the latent phase].
    GRUN L; REDIES H
    Klin Wochenschr; 1953 Oct; 31(37-38):894-5. PubMed ID: 13097952
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in bacterial sensitivity to aureomycin and chloramphenicol in the course of the past three years.
    SCHNEIERSON SS
    J Lab Clin Med; 1952 Jul; 40(1):48-57. PubMed ID: 14938747
    [No Abstract]   [Full Text] [Related]  

  • 16. AUREOMYCIN and riboflavin metabolism in microorganisms.
    Nutr Rev; 1954 Mar; 12(3):92-4. PubMed ID: 13133208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies on increasing bacterial resistance to streptomycin and aureomycin].
    MEYER G; DRUDE A
    Z Hyg Infektionskr; 1953 Jan; 136(3):233-44. PubMed ID: 13090988
    [No Abstract]   [Full Text] [Related]  

  • 18. Aureomycin; a new antibiotic with a special reference to its action on Shigella (dysenteric group of organisms).
    SUBBA RAO KV
    Antiseptic; 1951 Oct; 48(10):789-806. PubMed ID: 14878433
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of dietary aureomycin upon the intestinal microflora and the intestinal synthesis of vitamin B12 in the rat.
    JOHANSSON KR; PETERSON GE; DICK EC
    J Nutr; 1953 Jan; 49(1):135-52. PubMed ID: 13023465
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro determinations of bacterial sensitivity to aureomycin.
    THJØTTA T; RASCH S; JONSEN J
    Acta Pathol Microbiol Scand; 1954; 34(6):571-6. PubMed ID: 13206759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.